Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774).

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Abstract Text:

H E Wilson,R W Monto,A V Pisciotta,R J Rohn,J Louis,

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Publishing Authors By Initials

HE Wilson,RW Monto,AV Pisciotta,RJ Rohn,J Louis,

For similar heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 53

Page Numbers: 121-6

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Apr

YEAR: 1969

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Keywords Mesh Terms:

KEYWORDS: Piperazines

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774). Information

Substance Name: Piperazines

Registry Number: 0

Grant and Affiliation Information for Treatment of chronic granulocytic leukemia with piposulfan (NSC-47774).

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of chronic granulocytic leukemia with piposulfan NSC-47774 Related Publications

• Anatomical ontologies of mosquitoes and ticks, and their web browsers in VectorBase.
• Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level.
• Comment on "Superficial palmar communications between the ulnar and median nerves in Turkish cadavers".
• Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major.
• Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.
• Essential tremor.
• Essential tremor: emerging views of a common disorder.
• Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
• Gestational age and gestational age-at-delivery: cause, effect, or time-scale?
• Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate.
• Initial approach to the child who presents in presumed septic shock.
• Intracellular calcium regulation of connexin43.
• Kinetic tremor: differences between smokers and non-smokers.
• Localization of telomeres and telomere-associated proteins in telomerase-negative Saccharomyces cerevisiae.
• Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex.
• Mediterranean diet and essential tremor. A case-control study.
• Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.
• Molecular pathology of malignant gliomas.
• Neurologic Manifestations ofWhipple's Disease.
• PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer.
• Plasma renin and angiotensin levels in human hypertension following treatment.
• Plasma renin, urinary sodium excretion and vascular disease.
• Prevalence of taurodontism in premolars among patients at a tertiary care institution in Trinidad.
• Reflux disease and Barrett's esophagus.
• Risk and opportunity in upgrading the US drinking water infrastructure system.
• Silas Weir Mitchell's essential tremor.
• Variation in quality of diabetes care at the levels of patient, physician, and clinic.
• [Innovative therapies in inflammatory bowel disease at the CHU]
• [Lung cancer. Epidemiology and etiologic factors]
• [Not Available.]